BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3294123)

  • 1. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients.
    Ceccatelli P; Janssens J; Vantrappen G; Cucchiara S
    Gut; 1988 May; 29(5):631-5. PubMed ID: 3294123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
    Wienbeck M; Li Q
    Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
    Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
    Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
    Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R
    Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of gastro-oesophageal reflux in cystic fibrosis.
    Cucchiara S; Santamaria F; Andreotti MR; Minella R; Ercolini P; Oggero V; de Ritis G
    Arch Dis Child; 1991 May; 66(5):617-22. PubMed ID: 2039253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children.
    Cucchiara S; Campanozzi A; Greco L; Franco MT; Emiliano M; Alfieri E; Calabrese F; Numeroso V
    Am J Gastroenterol; 1996 Apr; 91(4):680-5. PubMed ID: 8677928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cisapride on postprandial gastro-oesophageal reflux.
    Holloway RH; Downton J; Mitchell B; Dent J
    Gut; 1989 Sep; 30(9):1187-93. PubMed ID: 2680794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease.
    Finizia C; Lundell L; Cange L; Ruth M
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):9-14. PubMed ID: 11782569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and treatment of gastro-oesophageal reflux disease.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 165():7-12; discussion 27-8. PubMed ID: 2574907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cisapride on the gastro-oesophageal function in normal human subjects.
    Wallin L; Kruse-Andersen S; Madsen T; Boesby S
    Digestion; 1987; 37(3):160-5. PubMed ID: 3653529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cisapride on distal esophageal motility in humans.
    Corazziari E; Bontempo I; Anzini F
    Dig Dis Sci; 1989 Oct; 34(10):1600-5. PubMed ID: 2791812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisapride for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S
    Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease.
    Ruth M; Finizia C; Cange L; Lundell L
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1115-21. PubMed ID: 14501621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cisapride, a new gastrointestinal prokinetic substance, on interdigestive and postprandial motor activity of the distal oesophagus in man.
    Smout AJ; Bogaard JW; Grade AC; ten Thije OJ; Akkermans LM; Wittebol P
    Gut; 1985 Mar; 26(3):246-51. PubMed ID: 3882526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cisapride, a new prokinetic agent, on esophageal motor function.
    Gilbert RJ; Dodds WJ; Kahrilas PJ; Hogan WJ; Lipman S
    Dig Dis Sci; 1987 Dec; 32(12):1331-6. PubMed ID: 3691273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisapride and the lazy lower oesophageal sphincter.
    Dent J
    J Gastroenterol Hepatol; 1989; 4(5):490-1. PubMed ID: 2491215
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study.
    Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P
    Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.